Inhalation Tuesday, April 24, 2018
Skip Navigation LinksHome) Webinar 2014-04/01 Formulations for Dry Powder
Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.

Formulations for Dry Powder Inhalers: Defining the Critical
Material Attributes of Crystals, Particles, and Powders

Tuesday, April 1, 2014

Time:  12:00 PM (Noon) – 2:00 PM EDT

Presented by:  Dr. Jag Shur, Research Fellow, University of Bath School of Pharmacy and Pharmacology

Guest Moderator:  Dr. Craig Davies-Cutting, Director, Inhaled Products & Technologies, Catalent Pharma Solutions

Moderated by:  Vicki Schuman, Editor of Inhalation

Webinar Cost:  $99.00 USD

Registration fee is non-refundable after the live event.

Webinar Details:  For dry powder inhalers (DPIs), control and reduction of risk during drug product development can only be achieved by introducing a material-science-based approach to understanding how physicochemical properties of the input ingredients and processing conditions influence formulation structure and product functionality. This webinar aims to provide a road map for material characterization of active pharmaceutical ingredients and excipients for the successful development of DPI drug products.

The key issues to be addressed are understanding the critical attributes of input materials, how they are influenced by processing, and their effect on the dynamics of particle deaggregation within a DPI device. An overview of the relationships between physicochemical properties of raw materials and their influence on the different stages of powder evacuation from the DPI and predicting deagglomeration efficiency will be explored.

The webinar’s guest moderator will be Dr. Craig Davies-Cutting of Catalent Pharma Solutions.

Presenter Information:  Dr. Jag Shur is a Research Fellow at the University of Bath School of Pharmacy and Pharmacology, where he conducts research investigating permeability and dissolution characteristics of combination drug products. He also supervises research projects at the University of Bath funded by the US FDA into bioequivalence of dry powder and metered dose inhalers. Dr. Shur is also Director of Nanopharm Ltd., a specialist research organization that focuses on the development of inhaled medicines. He has BSc. (Hons.) in Pharmaceutical Sciences and completed his Ph.D. entitled “Formulated Muco-Regulatory Agents in the Airways of Patients with Cystic Fibrosis” at the Portsmouth School of Pharmacy. Following this, he was a post-doctoral fellow at the London School of Pharmacy investigating the fabrication of microparticles for vaccine delivery using supercritical fluid technology. He began his career with Profile Drug Delivery, where he was developing liquid dose drug delivery systems for cystic fibrosis patients and went on to work for GlaxoSmithKline

Can’t attend?  If you register for a webinar but can't attend the live event, an archived version will be accessible online for 30 days once it concludes. This allows you to view the entire webinar presentation and Q&A session at a time most convenient to your schedule.

PDH Information:  If you are working on a certification or licensing program that allows Professional Development Hours, CSC Publishing Inc. will (upon request) provide a Certificate of Participation for our educational webinars put on by Inhalation. One certificate per registered participant will be sent if the webinar is viewed. You should check with your employer or local agency to confirm their specific PDH requirements. In many cases, our educational webinars will contribute toward these hours.

      Copyright 2018, CSC Publishing Inc. ALL Rights Reserved * Privacy policy